New Biomarkers of antitumor T cells asspcoate woth improved prognosis in endometrial cancer


The T-cell infiltrate of 47 endometrial tumors has been analyzed with the aim of defining tumor-reactive CD8+ and CD4+ TIL populations that could be very valuable in identifying prognostic and predict...

Read more

A therapeutic target for the treatment of endometrial cancer with mutations in the ARID1A gene has been identified

by IRB Lleida. Institut de Recerca Biomèdica

Research led by the Oncological Pathology research group at the Institute for Research in Biomedicine of Lleida (IRBLleida), the University of Lleida (UdL) and the Department of Pathological Anatomy o...

Read more

A study evaluates the effectiveness of colon and gynecological surgeries and their risk reduction in patients affected by Lynch syndrome

by Hospital Universitari de Bellvitge

he results show that this type of surgery can represent a good option for people affected by this syndrome since it supposes a reduction in the incidence of cancer and its mortality.

Read more

Promega Developing OncoMate™ MSI Assay as Companion Diagnostic for Endometrial Cancer Drug Candidate from Incyte

by Promega Biotech Ibérica

Promega Corporation announced today its intent to develop the Promega OncoMate™ microsatellite instability (MSI) Assay as a companion diagnostic test for retifanlimab, Incyte’s anti-PD-1 drug cand...

Read more

Ability Pharmaceuticals Announces the Presentation of the First Results of ABTL0812 as First Line in Patients with Endometrial or Lung Cancer at 2019 ASCO Annual Meeting

by Ability Pharma

​AbilityPharma (Ability Pharmaceuticals, SL) a biopharmaceutical company developing oncology drugs, announced today that the company will release the first results of the currently ongoing phase 1/2...

Read more

MIT selects a project to develop a new molecular kit for the diagnosis of endometrial cancer

by Vall d’Hebron

The Massachusetts Institute of Technology (MIT) through the Foundation for Innovation and the Prospective Health in Spain (FIPSE) has selected, from among hundreds of proposals, the CEMARK project to ...

Read more

The Biomedical Research group in Gynecology at VHIR receives a grant from CaixaImpulse

by Vall d’Hebron

The group of Biomedical Research in Gynecology of the Vall d'Hebron Research Institute (VHIR), led by Dr. Antonio Gil, has received one of 20 grants from the 2nd edition of CaixaImpulse, awarded by th...

Read more

Ability Pharmaceuticals Initiates Phase 2 Combination Trial with ABTL0812 as First Line Therapy in Patients with Endometrial or Squamous Lung Cancer Patients

by Ability Pharma

ABTL0812 is administered in combination with carboplatin and paclitaxel. Vall d’Hebron Institute of Oncology (VHIO, Barcelona) and Catalan Institute of Oncology (ICO, L’Hospitalet, Barcelona) lead...

Read more

Ability Pharmaceuticals enters into a licensing agreement with SciClone Pharmaceuticals for the novel anticancer agent ABTL0812 for the China market

by Ability Pharma

Collaboration boosts development of a fully differentiated inhibitor of the PI3K/Akt/mTOR pathway. ABTL0812 is currently in Phase 2 clinical trials to treat lung and endometrial cancers.

Read more
Subscribe to Directory
Write an Article

Recent News

Tuneable reverse photochromes in the sol...

A new technique allows the design of solid materia...

La Unidad de Chequeos de la Clínica sup...

El estudio realizado sobre una muestra significati...


Eosinófilos. ¿Qué significa tener val...

by Labo'Life

​En nuestro post hablamos sobre este interesante tipo de célula del...

Las células madre sanguíneas son susce...

by Revista Genética Médica

Un reciente estudio realizado por investigaciones del Broad Institute ...

Photos Stream